EUROPE 3D BIOPRINTING MARKET FORECAST 2023-2032
The Europe 3D bioprinting market is predicted to register a CAGR of 16.64% during the forecast period, 2023-2032, and is evaluated to reach a revenue of $1700.18 million by 2032.
EUROPE 3D BIOPRINTING MARKET FORECAST 2023-2032
Europe 3D Bioprinting Market by Component (3d Bioprinter, Bioink) Market by Biomaterial (Hydrogel, Living Cells, Extracellular Matrices, Other Biomaterials) Market by Technology (Magnetic Levitation Bioprinting, Inkjet-based Bioprinting, Syringe/extrusion-based Bioprinting, Laser-assisted Bioprinting, Other Technologies) Market by Application (Drug Testing & Development, Tissue Engineering & Regenerative Medicine, Food Testing, Research, Other Applications) Market by End-user (Hospitals, Biopharmaceuticals Companies, Research Organizations and Academic Institutes, Other End-users) by Geography
The Europe 3D bioprinting market is predicted to register a CAGR of 16.64% during the forecast period, 2023-2032, and is evaluated to reach a revenue of $1700.18 million by 2032.
The 3D bioprinting market growth in Europe is accredited to favorable government support, advanced healthcare systems, declining birth rates, rising elderly population, and well-developed healthcare insurance programs. In addition, the increasing research & development activities by renowned institutions and government agencies propel market growth opportunities.
Further, the Europe 3D bioprinting market is dominated by tissue engineering products like bioscaffolds and autologous chondrocyte transplantation therapies. At the same time, a majority of products are still under development.
To know more about this report, request a free sample copy
The Europe 3D bioprinting market growth evaluation includes the analysis of Germany, the United Kingdom, Italy, France, Nordic Countries, Spain, and Rest of Europe. The United Kingdom has advanced healthcare systems and invests significantly in healthcare IT infrastructure and data interoperability standards. In September 2019, the UK Ministry of Defence (MoD) announced new methods to leverage technologies like additive manufacturing and AI to strengthen national security. Accordingly, the MoD identifies 3D bioprinting and 3D printable sensors as necessary to harness new data types regarding platform and human performance.
Furthermore, as per stats, 1 in 4 people in the UK will be over 65 by 2050. Accordingly, local authorities and health services are reconfiguring healthcare by emphasizing efficient technology use and community care. Such aspects facilitate 3D bioprinting in healthcare in the UK. Also, the growing number of research & development initiatives associated with 3D bioprinting offers growth opportunities. For instance, the University of Plymouth is developing a working skin substitute that can mimic functional human skin using a 3D bioprinter.
In Spain, there has been a significant surge in funding initiatives for bioprinting research. The advanced therapies market is thriving in the country, making substantial strides in gene and cell therapies. For instance, Creatio UB has emerged as a prominent center in Europe for its production of gene and cell therapies for different therapeutic applications. However, the lack of tissue production facilities for regenerative medicine slows down the development of ambitious projects.
Furthermore, some companies are engaging in collaborations to expand their product portfolio. For instance, Regemat 3D is a leading bioprinting company that collaborates with research centers and hospitals to launch promising applications its employees develop. These include corneal regeneration, the printing of skin, heart, and bone & cartilage tissues, tissue models for drug development, and alternative models for animal studies. Such factors drive market growth in these countries.
The segmentation of the Europe 3D bioprinting market includes biomaterial, end-user, component, technology, and application. The component segment includes bioink and 3D bioprinter.
Biomaterials’ growth is primarily propelled by the growing demand for regenerative medicines. Biomaterials supplement and promote cell growth and differentiation to enable tissue lesion healing. Besides, biomimetic synthetic analogs’ preparation is possible due to bioinspired methodologies.
Furthermore, there has been continuous research to develop medical implants useful for accelerating the storing and healing of the physiological functions of bone. For instance, in March 2021, Lund University designed a new bioink that enables the 3D bioprinting of small human-sized airways using patient cells.
Some of the eminent companies in the Europe 3D bioprinting market are GeSiM GmbH, Organovo Holdings Inc, EnvisionTEC Ṁ Inc, Inventia Life Science Pty Ltd, etc.
GeSiM GmbH is an established provider of microcontact printing, microfluidics, and liquid handling automation. It develops and designs piezoelectric pipetting tips based on silicon-glass chips. Also, it provides micro-contact printers that offer liquid handling by contact printing. The company majorly operates in Europe, with headquarters in Radeberg, Germany.
One of its key products, BS3.3 Prime, is a bioprinter that includes a set of tools for easy printing of the most popular bioninks.
Report Synopsis
|
Report Scope |
Details |
| Market Forecast Years | 2023-2032 |
| Base Year | 2022 |
| Market Historical Years | 2018-2022 |
| Forecast Units | Revenue ($ Million) |
| Segments Analyzed | End-User, Application, Technology, Biomaterial, Component |
| Countries Analyzed | Germany, the United Kingdom, Italy, France, Nordic Countries, Spain, and Rest of Europe |
| Companies Analyzed |
3D Bioprinting Solutions, Advanced Solutions Life Sciences, Allevi, CELLINK, CollPlant Biotechnologies Ltd, Cyfuse Biomedical KK, EnvisionTEC Ṁ Inc, GeSiM GmbH, Inventia Life Science Pty Ltd, Organovo Holdings Inc, Regemat 3D, REGENHU, Revotek Co Ltd, ROKIT Healthcare Inc, Stratasys Ltd |
To request a free sample copy of this report, please complete the form below:
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.
- RESEARCH SCOPE & METHODOLOGY
- STUDY OBJECTIVES
- METHODOLOGY
- ASSUMPTIONS & LIMITATIONS
- EXECUTIVE SUMMARY
- MARKET SIZE & ESTIMATES
- MARKET OVERVIEW
- SCOPE OF STUDY
- CRISIS SCENARIO ANALYSIS
- IMPACT OF COVID-19 ON 3D BIOPRINTING MARKET
- MAJOR MARKET FINDINGS
- EMERGENCE OF 4D BIOPRINTING AS A SUBSTITUTE FOR 3D BIOPRINTING
- PERSONALIZED MEDICINE LIKELY TO BOOST 3D BIOPRINTING
- RISING INTEREST IN THE APPLICATION OF BIOPRINTING AGAINST THE SARS-COV-2 VIRUS
- MARKET DYNAMICS
- KEY DRIVERS
- SURGING GERIATRIC POPULATION
- TECHNOLOGICAL ADVANCEMENTS AND R&D INVESTMENTS
- RISING FOCUS ON REGENERATIVE MEDICINE
- HIGH PREVALENCE OF CHRONIC CONDITIONS
- KEY RESTRAINTS
- OPERATIONAL CHALLENGES DURING MANUFACTURING
- EXORBITANT COSTS OF 3D BIOPRINTERS
- LACK OF TRAINED PROFESSIONALS
- KEY DRIVERS
- KEY ANALYTICS
- PARENT MARKET ANALYSIS
- KEY MARKET TRENDS
- PORTER’S FIVE FORCES ANALYSIS
- BUYERS POWER
- SUPPLIERS POWER
- SUBSTITUTION
- NEW ENTRANTS
- INDUSTRY RIVALRY
- GROWTH PROSPECT MAPPING
- GROWTH PROSPECT MAPPING IN GERMANY
- MARKET MATURITY ANALYSIS
- MARKET CONCENTRATION ANALYSIS
- VALUE CHAIN ANALYSIS
- DESIGN & SOFTWARE PROVIDERS
- PROTOTYPE PRODUCTION
- DISTRIBUTION
- END-USERS
- MARKET BY COMPONENT
- 3D BIOPRINTER
- BIOINK
- MARKET BY BIOMATERIAL
- HYDROGEL
- LIVING CELLS
- EXTRACELLULAR MATRICES
- OTHER BIOMATERIALS
- MARKET BY TECHNOLOGY
- MAGNETIC LEVITATION BIOPRINTING
- INKJET-BASED BIOPRINTING
- SYRINGE/EXTRUSION-BASED BIOPRINTING
- LASER-ASSISTED BIOPRINTING
- OTHER TECHNOLOGIES
- MARKET BY APPLICATION
- DRUG TESTING & DEVELOPMENT
- TISSUE ENGINEERING & REGENERATIVE MEDICINE
- FOOD TESTING
- RESEARCH
- OTHER APPLICATIONS
- MARKET BY END-USER
- HOSPITALS
- BIOPHARMACEUTICALS COMPANIES
- RESEARCH ORGANIZATIONS AND ACADEMIC INSTITUTES
- OTHER END-USERS
- GEOGRAPHICAL ANALYSIS
- EUROPE
- MARKET SIZE & ESTIMATES
- EUROPE 3D BIOPRINTING MARKET DRIVERS
- EUROPE 3D BIOPRINTING MARKET CHALLENGES
- EUROPE 3D BIOPRINTING MARKET REGULATORY FRAMEWORK
- KEY PLAYERS IN EUROPE 3D BIOPRINTING MARKET
- COUNTRY ANALYSIS
- UNITED KINGDOM
- UNITED KINGDOM 3D BIOPRINTING MARKET SIZE & OPPORTUNITIES
- GERMANY
- GERMANY 3D BIOPRINTING MARKET SIZE & OPPORTUNITIES
- FRANCE
- FRANCE 3D BIOPRINTING MARKET SIZE & OPPORTUNITIES
- ITALY
- ITALY 3D BIOPRINTING MARKET SIZE & OPPORTUNITIES
- SPAIN
- SPAIN 3D BIOPRINTING MARKET SIZE & OPPORTUNITIES
- NORDIC COUNTRIES
- NORDIC COUNTRIES 3D BIOPRINTING MARKET SIZE & OPPORTUNITIES
- REST OF EUROPE
- REST OF EUROPE 3D BIOPRINTING MARKET SIZE & OPPORTUNITIES
- UNITED KINGDOM
- EUROPE
- COMPETITIVE LANDSCAPE
- KEY STRATEGIC DEVELOPMENTS
- MERGERS & ACQUISITIONS
- PRODUCT LAUNCHES & DEVELOPMENTS
- PARTNERSHIPS & AGREEMENTS
- COMPANY PROFILES
- 3D BIOPRINTING SOLUTIONS
- COMPANY OVERVIEW
- PRODUCTS LIST
- ADVANCED SOLUTIONS LIFE SCIENCES
- COMPANY OVERVIEW
- PRODUCTS LIST
- ALLEVI
- COMPANY OVERVIEW
- PRODUCTS LIST
- CELLINK
- COMPANY OVERVIEW
- PRODUCTS LIST
- STRENGTHS & CHALLENGES
- COLLPLANT BIOTECHNOLOGIES LTD
- COMPANY OVERVIEW
- PRODUCTS LIST
- CYFUSE BIOMEDICAL KK
- COMPANY OVERVIEW
- PRODUCTS LIST
- STRENGTHS & CHALLENGES
- ENVISIONTEC ṁ INC
- COMPANY OVERVIEW
- PRODUCTS LIST
- STRENGTHS & CHALLENGES
- GESIM GMBH
- COMPANY OVERVIEW
- PRODUCTS LIST
- STRENGTHS & CHALLENGES
- INVENTIA LIFE SCIENCE PTY LTD
- COMPANY OVERVIEW
- PRODUCTS LIST
- ORGANOVO HOLDINGS INC
- COMPANY OVERVIEW
- PRODUCTS LIST
- STRENGTHS & CHALLENGES
- REGEMAT 3D
- COMPANY OVERVIEW
- PRODUCTS LIST
- STRENGTHS & CHALLENGES
- REGENHU
- COMPANY OVERVIEW
- PRODUCTS LIST
- STRENGTHS & CHALLENGES
- REVOTEK CO LTD
- COMPANY OVERVIEW
- PRODUCTS LIST
- ROKIT HEALTHCARE INC
- COMPANY OVERVIEW
- PRODUCTS LIST
- STRATASYS LTD
- COMPANY OVERVIEW
- PRODUCTS LIST
- 3D BIOPRINTING SOLUTIONS
- KEY STRATEGIC DEVELOPMENTS
LIST OF TABLES
TABLE 1: MARKET SNAPSHOT – 3D BIOPRINTING
TABLE 2: COMPARATIVE SUMMARY OF 3D BIOPRINTING TECHNOLOGIES
TABLE 3: LIST OF APPROVED TISSUE-ENGINEERED MEDICAL PRODUCTS (TEMPS) USED IN VARIOUS COUNTRIES
TABLE 4: EUROPE 3D BIOPRINTING MARKET, BY COMPONENT, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 5: EUROPE 3D BIOPRINTING MARKET, BY COMPONENT, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 6: EUROPE 3D BIOPRINTING MARKET, BY BIOMATERIAL, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 7: EUROPE 3D BIOPRINTING MARKET, BY BIOMATERIAL, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 8: EUROPE 3D BIOPRINTING MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 9: EUROPE 3D BIOPRINTING MARKET, BY TECHNOLOGY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 10: EUROPE 3D BIOPRINTING MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 11: EUROPE 3D BIOPRINTING MARKET, BY APPLICATION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 12: EUROPE 3D BIOPRINTING MARKET, BY END-USER, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 13: EUROPE 3D BIOPRINTING MARKET, BY END-USER, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 14: EUROPE 3D BIOPRINTING MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 15: EUROPE 3D BIOPRINTING MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 16: EUROPE 3D BIOPRINTING MARKET REGULATORY FRAMEWORK
TABLE 17: KEY PLAYERS OPERATING IN EUROPE 3D BIOPRINTING MARKET
TABLE 18: LIST OF MERGERS & ACQUISITIONS
TABLE 19: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 20: LIST OF PARTNERSHIPS & AGREEMENTS
LIST OF FIGURES
FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER’S FIVE FORCES ANALYSIS
FIGURE 3: GROWTH PROSPECT MAPPING FOR GERMANY
FIGURE 4: MARKET MATURITY ANALYSIS
FIGURE 5: MARKET CONCENTRATION ANALYSIS
FIGURE 6: VALUE CHAIN ANALYSIS
FIGURE 7: EUROPE 3D BIOPRINTING MARKET, GROWTH POTENTIAL, BY COMPONENT, IN 2022
FIGURE 8: EUROPE 3D BIOPRINTING MARKET, BY 3D BIOPRINTER, 2023-2032 (IN $ MILLION)
FIGURE 9: EUROPE 3D BIOPRINTING MARKET, BY BIOINK, 2023-2032 (IN $ MILLION)
FIGURE 10: EUROPE 3D BIOPRINTING MARKET, GROWTH POTENTIAL, BY BIOMATERIAL, IN 2022
FIGURE 11: EUROPE 3D BIOPRINTING MARKET, BY HYDROGEL, 2023-2032 (IN $ MILLION)
FIGURE 12: EUROPE 3D BIOPRINTING MARKET, BY LIVING CELLS, 2023-2032 (IN $ MILLION)
FIGURE 13: EUROPE 3D BIOPRINTING MARKET, BY EXTRACELLULAR MATRICES, 2023-2032 (IN $ MILLION)
FIGURE 14: EUROPE 3D BIOPRINTING MARKET, BY OTHER BIOMATERIALS, 2023-2032 (IN $ MILLION)
FIGURE 15: EUROPE 3D BIOPRINTING MARKET, GROWTH POTENTIAL, BY TECHNOLOGY, IN 2022
FIGURE 16: EUROPE 3D BIOPRINTING MARKET, BY MAGNETIC LEVITATION BIOPRINTING, 2023-2032 (IN $ MILLION)
FIGURE 17: EUROPE 3D BIOPRINTING MARKET, BY INKJET-BASED BIOPRINTING, 2023-2032 (IN $ MILLION)
FIGURE 18: EUROPE 3D BIOPRINTING MARKET, BY SYRINGE/EXTRUSION-BASED BIOPRINTING, 2023-2032 (IN $ MILLION)
FIGURE 19: EUROPE 3D BIOPRINTING MARKET, BY LASER-ASSISTED BIOPRINTING, 2023-2032 (IN $ MILLION)
FIGURE 20: EUROPE 3D BIOPRINTING MARKET, BY OTHER TECHNOLOGIES, 2023-2032 (IN $ MILLION)
FIGURE 21: EUROPE 3D BIOPRINTING MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2022
FIGURE 22: EUROPE 3D BIOPRINTING MARKET, BY DRUG TESTING & DEVELOPMENT, 2023-2032 (IN $ MILLION)
FIGURE 23: EUROPE 3D BIOPRINTING MARKET, BY TISSUE ENGINEERING & REGENERATIVE MEDICINE, 2023-2032 (IN $ MILLION)
FIGURE 24: EUROPE 3D BIOPRINTING MARKET, BY FOOD TESTING, 2023-2032 (IN $ MILLION)
FIGURE 25: EUROPE 3D BIOPRINTING MARKET, BY RESEARCH, 2023-2032 (IN $ MILLION)
FIGURE 26: EUROPE 3D BIOPRINTING MARKET, BY OTHER APPLICATIONS, 2023-2032 (IN $ MILLION)
FIGURE 27: EUROPE 3D BIOPRINTING MARKET, GROWTH POTENTIAL, BY END-USER, IN 2022
FIGURE 28: EUROPE 3D BIOPRINTING MARKET, BY HOSPITALS, 2023-2032 (IN $ MILLION)
FIGURE 29: EUROPE 3D BIOPRINTING MARKET, BY BIOPHARMACEUTICALS COMPANIES, 2023-2032 (IN $ MILLION)
FIGURE 30: EUROPE 3D BIOPRINTING MARKET, BY RESEARCH ORGANIZATIONS AND ACADEMIC INSTITUTES, 2023-2032 (IN $ MILLION)
FIGURE 31: EUROPE 3D BIOPRINTING MARKET, BY OTHER END-USERS, 2023-2032 (IN $ MILLION)
FIGURE 32: EUROPE 3D BIOPRINTING MARKET, COUNTRY OUTLOOK, 2022 & 2032 (IN %)
FIGURE 33: UNITED KINGDOM 3D BIOPRINTING MARKET, 2023-2032 (IN $ MILLION)
FIGURE 34: GERMANY 3D BIOPRINTING MARKET, 2023-2032 (IN $ MILLION)
FIGURE 35: FRANCE 3D BIOPRINTING MARKET, 2023-2032 (IN $ MILLION)
FIGURE 36: ITALY 3D BIOPRINTING MARKET, 2023-2032 (IN $ MILLION)
FIGURE 37: SPAIN 3D BIOPRINTING MARKET, 2023-2032 (IN $ MILLION)
FIGURE 38: NORDIC COUNTRIES 3D BIOPRINTING MARKET, 2023-2032 (IN $ MILLION)
FIGURE 39: REST OF EUROPE 3D BIOPRINTING MARKET, 2023-2032 (IN $ MILLION)
- GEOGRAPHICAL ANALYSIS
- EUROPE
- MARKET SIZE & ESTIMATES
- EUROPE 3D BIOPRINTING MARKET DRIVERS
- EUROPE 3D BIOPRINTING MARKET CHALLENGES
- EUROPE 3D BIOPRINTING MARKET REGULATORY FRAMEWORK
- KEY PLAYERS IN EUROPE 3D BIOPRINTING MARKET
- COUNTRY ANALYSIS
- UNITED KINGDOM
- UNITED KINGDOM 3D BIOPRINTING MARKET SIZE & OPPORTUNITIES
- GERMANY
- GERMANY 3D BIOPRINTING MARKET SIZE & OPPORTUNITIES
- FRANCE
- FRANCE 3D BIOPRINTING MARKET SIZE & OPPORTUNITIES
- ITALY
- ITALY 3D BIOPRINTING MARKET SIZE & OPPORTUNITIES
- SPAIN
- SPAIN 3D BIOPRINTING MARKET SIZE & OPPORTUNITIES
- NORDIC COUNTRIES
- NORDIC COUNTRIES 3D BIOPRINTING MARKET SIZE & OPPORTUNITIES
- REST OF EUROPE
- REST OF EUROPE 3D BIOPRINTING MARKET SIZE & OPPORTUNITIES
- UNITED KINGDOM
- EUROPE
- MARKET BY COMPONENT
- 3D BIOPRINTER
- BIOINK
- MARKET BY BIOMATERIAL
- HYDROGEL
- LIVING CELLS
- EXTRACELLULAR MATRICES
- OTHER BIOMATERIALS
- MARKET BY TECHNOLOGY
- MAGNETIC LEVITATION BIOPRINTING
- INKJET-BASED BIOPRINTING
- SYRINGE/EXTRUSION-BASED BIOPRINTING
- LASER-ASSISTED BIOPRINTING
- OTHER TECHNOLOGIES
- MARKET BY APPLICATION
- DRUG TESTING & DEVELOPMENT
- TISSUE ENGINEERING & REGENERATIVE MEDICINE
- FOOD TESTING
- RESEARCH
- OTHER APPLICATIONS
- MARKET BY END-USER
- HOSPITALS
- BIOPHARMACEUTICALS COMPANIES
- RESEARCH ORGANIZATIONS AND ACADEMIC INSTITUTES
- OTHER END-USERS
To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.